Abstract: This invention relates to a composition based on a mixture of different olive oils, preferably virgin and extra virgin olive oils, from ecological farms, and to the use thereof in the treatment or prevention of different disorders in humans and animals. Moreover, this invention also relates to a dermatological/dermocosmetic preparation that comprises the composition of this invention and to the use of this dermatological/dermocosmetic preparation in the treatment of skin disorders in humans and animals. Underlying these systemic and/or skin disorders, there are metabolic and immunoinflammatory-oxidative alterations, which may be positively modified by the systemic (oral) or topical (cutaneous) use of the composition of this invention. The special physical-chemical structure of the composition allows for a better digestive and cutaneous arrangement.

Abstract: The invention relates to a method, to a device for electronic characterisation, and to a measurement cell and support for monitoring a chemical or physical process with results that can be assessed in terms of the weight variation of a coating deposited on a piezoelectric sensor, exposed to a fluid medium with stable physical properties. The invention uses the deduction of an analytic expression establishing a simple connection between the phase variation of a fixed-frequency signal, which queries the piezoelectric resonator, and the variation in the bulk density of the coating. The invention is suitable for implementations that use piezoelectric resonators for characterising biochemical and electrochemical processes, such as, inter alia: piezoelectric biosensors and immunosensors, process and material characterisation by AC electrogravimetry, detection of dissolved chemical or biological substances.

Abstract: The invention consists in a security paper, as well as the security document obtained with it and the manufacturing process thereof, that combines the security elements called windowed thread with the high contrast single-tone watermark technique. In order to carry out this invention, we make use of the recesses created to cover the thread in the areas where it is visible, which exhibit a greater accumulation of fibres and are therefore opaque areas in the final paper, to insert therein the electrotype or high contrast single-tone watermarks.

Abstract: The invention relates to a system for converting solar energy into mechanical or electrical energy, comprising: means for concentrating the solar radiation from the sun at a given focal point, collector means for receiving and accumulating the solar radiation originating from the concentration means in order to accumulate thermal energy, and means for converting the thermal energy accumulated in the collector means into mechanical energy. Subsequently, the mechanical energy can be converted into electrical energy using a conventional generator.

Abstract: It consists in performing a security paper or special paper incorporating pigments within the paste of the synthetic element itself during its manufacture, providing pigment properties to said synthetic element, the pigments being protected from the attack of physical and chemical agents by the synthetic element itself.

Abstract: A holder and battery charger system for portable electronic devices comprises a back panel and a releasably detachable front panel. The back panel itself comprised of a plurality of integrated sources of power for charging a device. Amongst the plurality of integrated sources of power for charging a device are: a flip out AC plug. a slide out USB connector sliding out from within the back panel. a car plug and a car plug sheath attached to the side of the back panel. a hand cranked dynamo and a dynamo holder that is attached to the side of the back panel. An interface connector electrically connects the universal holder and charger to the portable device. a belt clip connector with a releasably attached belt clip. a 9 volt battery snap connector.

Abstract: The invention relates to glycopeptidic glycoconjugates, in which the polysaccharide is obtained from Candida utilis cells and the peptides are obtained from Ricinus communis seeds. The glycoconjugates are used in the preparation of immunomodulating drugs that control the production of tumor necrosis factor (TNF).

Abstract: This invention relates to a process for the preparation of glucosamine sulfate, glucosamine hydroiodide, glucosamine pyruvate, glucosamine phosphate or their mixtures with glucosamine hydrochloride, by electrodialysis. Starting from glucosamine hydrochloride, the exchange of the Cl? for an anion selected from the group consisting of SO4 ?2, I?, CH3COCOO? and PO4?3 takes place during the process. The electrodialyser comprises a cathode, anode, and means of separation composed of anion exchange membranes, cation exchange membranes, bipolar membranes or by other suitable means of separation. This invention also relates to a glycosamine sulphate containing chlorides obtainable by the process, and its therapeutic use.

Abstract: This invention relates to a process for the preparation of glucosamine hydroiodide, glucosamine pyruvate, glucosamine phosphate or their mixtures with glucosamine hydrochloride, by electrodialysis. Starting from glucosamine hydrochloride, the exchange of the Cl? for an anion selected from the group consisting of SO4 ?2, I?, CH3COCOO? and PO4?3 takes place during the process. The electrodialysis, that comprises a cathode, anode, and means of separation composed of anion exchange membranes, cation exchange membranes, bipolar membranes or by other suitable means of separation. This invention also relates to a glycosamine sulphate containing chlorides obtainable by the process, and its therapeutic use.

Abstract: The invention relates to the use of phospholipases, v.gr. sPLA2, as an active agent in the production of pharmaceutical and/or cosmetic compositions for the treatment of diseases caused by micro-organisms, the envelope or membrane of which comprises phospholipids, particularly glycerophospholipids. In particular, said invention relates to the use of sPLA2 from Crotalus durissus terrificus venom as a biocide component for the preparation of compositions for the treatment of viral infections, particularly acquired immunodeficiency states VIH-1 and VIH-2, bacterial and parasitic infections, such as infections caused by plasmodium and leishmania-type parasites.

Abstract: The invention relates to the use of mutants of L. casei having at least a mutation impairing the regulation of a carbon catabolite repression (CCR) mechanism involving the PTS protein HPRr, for the preparation of a food product. The use of said mutants allows for instance to impart to said food products an improved texture and flavor, and/or a higher content in aroma compounds.

Abstract: The process comprises: (A) obtainment of N-acetyl-cysteine from L-cystine, by means of the following steps:(i) acetylation of L-cystine to produce N-acetyl-cystine;(ii) electroreduction and desalination by electrodialysis of the N-acetyl-cystine thus produced to give N-acetyl-cysteine; or (B) obtainment of N-acetyl-cysteine from L-cystine, by means of the following steps:(i) acetylation and desalination of L-cystine to produce N-acetyl-cystine;(ii) electroreduction of N-acetyl-cystine which may or may not come from the preceding step (i) to produce N-acetyl-cysteine; (C) obtainment of N-acetyl-cysteine from L-cystine by means of the following steps:(i) electroreduction of L-cystine to produce L-cysteine;(ii) acetylation and desalination by electrodialysis of L-cysteine, which may or may not come from the preceding step (i) to produce N-acetyl-cysteine.The N-acetyl-cysteine thus obtained has important uses in the pharmaceutical sector.